Management Options for Node-Positive Muscle-Invasive Bladder Cancer

被引：0
|
作者：
Polimera, V. [1 ]
Bhatia, Priyanka [1 ]
Wheelden, Megan [1 ]
Perimbeti, Stuthi [1 ]
Warrick, Joshua [2 ]
Joshi, Monika [1 ]
Joshi, Monika [1 ]
机构：
[1] Penn State Canc Inst, Dept Med, Div Hematol Oncol, Hershey, PA USA
[2] Penn State Hershey Med Ctr, Dept Pathol, Hershey, PA USA
来源：
CLINICAL ADVANCES IN HEMATOLOGY & ONCOLOGY | 2024年 / 22卷 / 08期
关键词：
Biomarker; chemotherapy; immunotherapy; node-positive muscle-invasive bladder cancer; radiation; METASTATIC UROTHELIAL CARCINOMA; CISPLATIN-INELIGIBLE PATIENTS; ADJUVANT CHEMOTHERAPY; OPEN-LABEL; NEOADJUVANT CHEMOTHERAPY; RADICAL CYSTECTOMY; SINGLE-ARM; TRANSURETHRAL SURGERY; MULTICENTER; THERAPY;
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
Localized node-positive bladder cancer is characterized by a high degree of heterogeneity, leading to significant variability in overall survival outcomes among affected individuals. The absence of standardized treatment guidelines presents a critical challenge in managing these patients effectively. This comprehensive review article delves into the pathophysiology, clinical significance, and management of node-positive bladder cancer. It critically evaluates the current therapeutic landscape and explores emerging treatment strategies, including novel drugs currently undergoing clinical trials. By synthesizing the latest research findings, the review aims to provide valuable insights into the optimal management of node-positive urothelial cell carcinoma, ultimately contributing to improved patient outcomes and quality of life.
引用
收藏
页码：392 / 402
页数：11
相关论文
共 50 条
  • [31] Aggressive management of elderly patients with muscle-invasive bladder cancer
    Weizer, Alon Z.
    Montie, James E.
    Lee, Cheryl T.
    NATURE CLINICAL PRACTICE UROLOGY, 2006, 3 (07): : 346 - 347
  • [32] Understanding patient perspectives in the management of their muscle-invasive bladder cancer
    Chowdhury, Deepro
    Apolo, Andrea B.
    Jiang, Di Maria
    Skinner, Eila C.
    Chisolm, Stephanie
    Bangs, Rick
    Maganti, Manjula
    Steinberg, Gary D.
    Kaag, Matthew
    Efstathiou, Jason A.
    Sridhar, Srikala S.
    BJU INTERNATIONAL, 2025,
  • [33] Optimal Management of the Elderly Patient with Muscle-Invasive Bladder Cancer
    Eugene J. Pietzak
    George W. Drach
    S. Bruce Malkowicz
    Thomas J. Guzzo
    Current Translational Geriatrics and Experimental Gerontology Reports, 2013, 2 (2): : 58 - 65
  • [34] Aggressive management of elderly patients with muscle-invasive bladder cancer
    Alon Z Weizer
    James E Montie
    Cheryl T Lee
    Nature Clinical Practice Urology, 2006, 3 : 346 - 347
  • [35] Radical Cystectomy and the Multidisciplinary Management of Muscle-Invasive Bladder Cancer
    Chedgy, Edmund Charles Paul
    Black, Peter C.
    JAMA ONCOLOGY, 2016, 2 (07) : 855 - 856
  • [36] Radical transurethral resection in the management of muscle-invasive bladder cancer
    Grob, BM
    Macchia, RJ
    JOURNAL OF ENDOUROLOGY, 2001, 15 (04) : 419 - 423
  • [37] The role of systemic chemotherapy in the management of muscle-invasive bladder cancer
    Juffs, HG
    Moore, MJ
    Tannock, IF
    LANCET ONCOLOGY, 2002, 3 (12): : 738 - 747
  • [38] Chemotherapy for Muscle-Invasive Bladder Cancer
    Patrizia Trenta
    Fabio Calabrò
    Linda Cerbone
    Cora N. Sternberg
    Current Treatment Options in Oncology, 2016, 17
  • [39] Chemotherapy for Muscle-Invasive Bladder Cancer
    Trenta, Patrizia
    Calabro, Fabio
    Cerbone, Linda
    Sternberg, Cora N.
    CURRENT TREATMENT OPTIONS IN ONCOLOGY, 2016, 17 (01) : 1 - 14
  • [40] Treatment of muscle-invasive bladder cancer
    Sherif, Amir
    Jonsson, Martin N.
    Wiklund, N. Peter
    EXPERT REVIEW OF ANTICANCER THERAPY, 2007, 7 (09) : 1279 - 1283
12345